Mesenchymal stromal cells (MSCs) can differentiate to various cell types including osteoblasts, chondrocytes, and adipocytes. This cellular flexibility contributes to widespread clinical use of MSCs in tissue repair. However, challenges remain in efficient cellular expansion of MSCs for stem cell therapy. Current MSC culture methods have resulted in reduced self-renewal of MSCs and compromised therapeutic outcomes. This study identifies that nicotinamide mononucleotide (NMN), a key natural NAD + intermediate, effectively encourages MSC expansion in vitro and in vivo. The in vitro expanded MSCs had heightened osteogenesis, but reduced adipogenesis. Furthermore, NMN supplementation stimulated osteogenesis of endogenous MSCs, and protected bone from aging and irradiation induced damage in mice. Mechanistically, we found that NMN treatment upregulated SIRT1. Genetically overexpressing SIRT1 in MSCs by using Prx1 cre; ColA1 flox-stop-flox-SIRT1 mice promoted osteogenesis and reduced adipogenesis in aged mice. Overall, our data demonstrate that NMN promoted MSC self-renewal with strengthened osteogenesis and reduced adipogenesis via upregulating SIRT1 in aged mice.
Introduction
Aging is predicted to be an increasingly serious health and financial problem worldwide 1 . Age-related disorders, such as tumor 2, 3 , metabolic disease 4 , memory deterioration 5 , and immunologic degeneration 6 , are associated with declined regenerative capacity in rapidly dividing stem cells 7 . Nicotinamide mononucleotide (NMN), a key NAD + intermediate which decreases with age in mammals 8 , is an efficient therapy against age-associated diseases 9, 10 . NMN administration alleviates age-related type 2 diabetes, ischemia-reperfusion injury, and Alzheimer's disease 11, 12 . However, the underlying mechanism of NMN's protective effect is still unknown. In this study, we explored NMN's role in combating age-related disorders via regulating mesenchymal stromal cells (MSCs). MSCs are nonhematopoietic multipotent stem cells with regeneration capacity 13 . Loss in number or functionality of MSCs with age profoundly limits tissue regeneration 14 , However, most current MSC culture methods limits selfrenewal potential and functionality of MSCs, leading to compromised therapeutic outcomes 10, 15 . Herein, we have investigated the effects and underlying mechanism of NMN on the expansion and differentiation of mouse MSCs in vitro and in vivo. We have found that NMN promotes MSC self-renewal during in vitro culture and in mice. We have further demonstrated that NMN activates Sirtuin1 (SIRT1), which is an NAD + -dependent deacetylase. NMN increases osteogenesis and reduces adipogenesis of MSCs via upregulating SIRT1 in aged mice.
Materials and methods

Mice and genotyping
The usage of NMN was according to previous studies 16, 17 . The mice used in this study included Prx1-Cre mice 18 and ColA1 flox-stop-flox-SIRT1 mice 19 . All mice were backcrossed at least six times onto a C57BL/6J background and housed in the Animal Resource Center of Sun Yat-Sen University. All procedures were approved by the Animal Resource Center of Sun Yat-Sen University Institutional Animal Care and Use Committee. For genotyping of prx1 cre + mice, the following primers were used: 5′-ATGTCCAATTTACTGA CCGTACA-3′ and 5′-CGCATAACCAGTGAAACAGCATT-3′. For genotyping of ColA1 flox-stop-flox-SIRT1 mice, the following primers were used: 5′-TGA CCT CCT CAT TGT TAT TGG A-3′ and 5′-GGC GTG GAG GTT TTT CAG T-3′.
Bone marrow digestion
The two primary methods used to isolate MSCs from bone marrow (BM), enzymatic digestion, and mechanical isolation. Our pre-experiment results showed that the enzymatic digestion method yields fourfold more MSCs than the mechanical isolation method (Fig. S1A-B) . Thus, we chose the enzymatic digestion method to acquire MSCs. The enzymatic digestion method was described previously 13, 16 . Intact marrow plugs were flushed from the femur and treated with digestion buffer containing 3 mg/ ml type I collagenase (Worthington, USA), 4 mg/ml dispase (Roche Diagnostic, USA) in HBSS with Ca 2+ and Mg 2+ .
Colony-forming unit-fibroblast (CFU-F) culture and differentiation CFU-F culture was performed as described previously 20, 21 . Briefly, cells acquired by the enzymatic digestion were seeded at a clonal density of 2.5 × 10 5 cells per well in six-well plates with DMEM (Gibco, USA) plus 10% fetal bovine serum (Gibco, USA), 10 mM ROCK inhibitor (Tocris, UK), and 1% penicillin/streptomycin (Invitrogen, USA).
Flow cytometry
The antibodies used to analyse MSCs included anti-CD45-APC (Clone 30-F11, 1:100; BioLegend, USA), antiTer119-APC (Clone TER-119, 1:100; BioLegend, USA), anti-CD31-PE-cy7 (Clone MEC13.3, 1:100; BioLegend, USA), anti-PDGFRα-biotin (Clone APA5, 1:200; eBioscience, USA), PE anti-mouse CD51 antibody (Clone RMV-7, 1:100; eBioscience, USA), anti-LepR-biotin antibody (BAF497,1:100; R&D Systems, USA), and Anti-Sca1-Percp-cy5.5 (eBioscience, USA).
MSCs differentiation in culture
MSCs acquired by the enzymatic digestion method were seeded at a clonal density of 2.5 × 10 5 cells per well in sixwell plates to form primary CFU-Fs for 1 week followed by adipogenic (1 week) or osteogenic (2 weeks) differentiation with StemPro Differentiation Kits (Invitrogen, USA).
MicroCT analysis
The procedure was performed according to previous studies 20, 22 .
Sublethal irradiation
For sublethal irradiation, C57BL/6J mice were X-ray irradiated with an XRAD 320 irradiator (Precision X-Ray, Inc.) at the dosage of 300 rad. Mice were maintained on antibiotic water for 14 days after irradiation.
Bone sectioning and staining
Dissected bones were fixed in 4% paraformaldehyde overnight, decalcified in 10% EDTA for 48 h and dehydrated in 30% sucrose for 2 days. Bones were sectioned (20 μM thickness) using a slicer (Thermo Scientific, USA). Sections were stained with an Oil Red S or Alizarin Red staining kit.
qPCR
For quantitative reverse transcription PCR, RNA was extracted, and reverse transcribed into cDNA using SuperScript III (Invitrogen, USA). qPCR was performed using a Roche LightCycler 480. The primers used for qPCR analysis included Runx2 (NM_001146038.2): 5′-TTA CCT ACA CCC CGC CAG TC-3′ and 5′-TGC TGG TCT GGA AGG GTC C-3′; Wnt4: 5′-CCGGGCACT-CATGAATCT-3′ and 5′-CACGCCAGCACGTCTTTA C-3′; Adipq: 5′-TGTTCCTCTTAATCCTGCCCA-3′ and 5′-CCAACCTGCACAAGTTCCCTT-3′; and Pparg: 5′-A CCACTCGCATTCCTTTGAC-3′ and 5′-TGGGTCAGC TCTTGTGAATG-3′.
Immunoblot analysis
The procedure was performed according to previous studies 23 . Proteins were detected using commercially available antisera (α-Tubulin Sigma, USA; SIRT1: Millipore, USA).
Caspase-3/7 activity measurement
were sorted from BM cells and seeded into 48-well plates at a density of 1.5 × 10 4 per well 24 . Apoptotic cells were detected by the Cell Event Caspase-3/7 Green Detection Reagent (Invitrogen, USA) according to the manufacturer's instructions. The cells were incubated with detection reagent for 30 min, followed by fixation and quantification.
EdU incorporation
MSCs or osteoblasts were sorted from BM cells and then seeded into 48-well plates at a density of 1.5 × 10 4 per well. EdU was added to the MSCs medium at day 0 (10 µM final concentration) and maintained for 48 h 13 . Cell proliferation was detected by the EdU Cell Proliferation Assay Kit (RiboBio, Guangzhou, China) according to the manufacturer's instructions. Cells were captured using a Leica fluorescent microscope equipped with a camera.
Statistical analysis
The statistical significance of differences between the two treatments was assessed using two-tailed Student's ttest. The statistical significance of differences among groups was assessed using one-way ANOVA with Tukey's multiple comparison tests. The statistical significance of differences in long-term competitive reconstitution assays was assessed using two-way ANOVA with Sidak's multiple comparison tests. All data represent the mean ± SD. *p < 0.05, **p < 0.01, ***p < 0.001.
Results
NMN promotes MSC expansion in vitro and in adult mice
To investigate the effects of NMN on the expansion of MSCs in vitro, we performed the CFU-F assay using enzymatically digested mouse BM cells administered with NMN (Fig. 1a) . The results showed that the CFU-F frequency increased in response to NMN administration in a dosage dependent manner (0.08-2.25 μM) (Fig. 1b, c ) and reached the maximum at the concentrations between 0.75 and 2.25 μM. NMN treatment at 0.03 and 0.08 μM did not show significant change in CFU-F frequency (Fig. 1c) . These results indicate that NMN promotes MSC expansion and may be a useful tool to enhance MSC frequency in vivo.
To investigate if NMN stimulates MSCs expansion in vivo, we analysed immunophenotypic MSCs 13, 20 (PDGFRα
+ stromal cells) from mice with NMN administration (Fig. 1d) . We found that the MSCs frequency increased to 0.50 ± 0.022% 3 months after NMN treatment ( Fig. 1e-g ) compared to the control group (0.30 ± 0.031%). Similarly, the frequency of
+ stromal cells increased to 0.51 ± 0.024% (Fig. 1f, g ) compared to the control group (0.30 ± 0.021%). Over 95% of
+ stromal cells were positive for PDGFRα and vice versa (Figs. S1C and 1g). However, we did not observe cellularity change in response to NMN treatment (Fig. 1h) . Altogether, our results suggest that NMN significantly encourages MSC expansion in vitro and in vivo.
Enhanced osteogenesis, but reduced adipogenesis in NMN-treated MSCs in vitro
To investigate the effects of NMN on MSCs differentiation in vitro, we induced CFU-F colonies to osteoblast and adipocyte lineages with NMN administration during differentiation (Fig. 2a) . We found significantly more osteoblasts (~50% Alizarin R + colonies) in the culture treated with NMN compared with~30% in the control group (Fig. 2b, d ). Moreover, we found a dosage dependent (0.03-2.25 μM) decrease in Oil Red O + colonies with 10% in NMN-treated cells and~37% from control cells (Fig. 2c, e) . We observed a substantial decrease of adipocyte differentiation in cells treated with NMN at concentrations between 0.75 (70% of Oil Red O + colonies) and 2.25 µM (68% of Oil Red O + colonies). These results are consistent with previous findings that the anti-aging compound resveratrol stimulated osteogenic differentiation, but inhibited adipogenic differentiation in human embryonic stem cell-derived mesenchymal progenitors 25 . Our qPCR analysis of NMN-treated cells (0.75 to 2.25 µM) showed significantly increased expression of RunX2 (Fig. 2f) , a critical transcription factor that promotes osteogenesis 26 . Similarly, the expression of Wnt4, a noncanonical Wnt ligand that promotes osteogenesis 27 , increased in the NMN-treated group (0.75-2.25 µM) (Fig.  2g) . In contrast, the expression level of key adipogenesis transcription factors such as Pparg and Adipq
28
, declined after NMN treatment (0.75 and 2.25 µM) (Fig. 2h, i) .
NMN does not change bone-fat balance in adult mice
We further explored the effects of NMN on osteogenesis and adipogenesis in vivo by administering NMN to 2-month-old mice for 3 months (Fig. 3a) . A microcomputed tomography (µCT) analysis of morphological parameters revealed that thickness, bone volume, and bone area of neither cortical nor trabecular bone changed in the femur of NMN-treated mice compared to controls (Fig. 3b-m) . These results indicate that NMN does not affect osteogenesis in adult mice.
To test the effects of NMN on generation of marrow adipose tissue (MAT) in adult mice, we prepared thick femur sections (20 µM) and stained them with Oil Red S. We did not find any significant difference between NMNtreated and control mice (Fig. 3n) . These data suggest that NMN does not affect adipogenesis in adult mice.
NMN potentiates bone accumulation and MAT loss in aged mice
Skeletal aging and osteoporosis occur when marrow MSCs aberrantly differentiate towards adipose lineage at the cost of osteogenesis, leading to compromised bone formation and loss of bone mass 29, 30 . Hence, we investigated the effects of NMN on lineage specification of marrow MSCs in aged mice by administrating NMN to 12-month-old mice (Fig. 4a) . Our µCT analysis revealed that cortical bone parameters in the femur diaphysis of the NMN treatment group were statistically nondistinct to the control group (Fig. 4b-f) . In contrast, the trabecular bone gained~1 per mm in number,~0.01 mm in thickness,~48% in trabecular bone connectivity density.
Consistently, NMN treatment also decreased trabecular spacing by~36% and structure model index by~33% (Fig.  4g-m) . Bone volume (BV/TV) did not change in the femur metaphysis of NMN-treated mice compared to control (Fig. 4h) . These results indicate that NMN stimulates osteogenesis in aged mice.
To test the implication of NMN on adipogenesis in aged mice, we quantified MAT after NMN treatment. Compared to 75 adipocytes per mm 2 in the control group, we observed significantly fewer adipocytes (30 adipocytes per mm 2 ) in the femur sections from NMN-treated mice than the control (Fig. 4n, o) . These data suggest that NMN inhibits adipogenesis in aged mice. Taken together, we demonstrated biased differentiation of MSCs towards bone lineage at the expense of adipocyte lineage after NMN treatment.
NMN facilitates the expansion of BM MSCs in irradiated adult mice
Since ionizing irradiation often leads to bone loss and damage to MSCs 31,32 , we evaluated the protection of NMN against irradiation of MSCs (Fig. 5a) . We found that the CFU-F ability of MSCs from irradiated mice was decreased by~75% compared to the control group. The NMN treatment restored the CFU-F ability of the irradiated MSCs to the level of the control group (Fig. 5b, c) . These results suggest that NMN protects MSCs after irradiation in vitro.
To investigate the protection of NMN on MSCs against irradiation in vivo, we measured the frequency of 5f ), and (Fig. S2A) . We found that the frequency of the above three subsets of MSCs from the irradiation group were decreased by~41% compared to the control group but were restored after NMN treatment to the level of the control group (Fig.  5d-f) . Moreover, the number of total nucleus cells (TNCs) slightly dropped in the irradiation group by~25% compared to the control group (Fig. 5g) but was again restored to the level of the control group after NMN treatment (Fig. 5g) . Furthermore, we found that irradiation inhibited EdU + proliferating MSC by 50%; and the inhibition on MSC proliferation was fully rescued by NMN treatment in irradiated mice (Fig S2B-D) . These results suggest that NMN is critical in protecting MSCs 
NMN potentiates bone accumulation and MAT loss in adult mice upon irradiation
Exposure to sublethal irradiation led to fewer osteoblast but more adipocyte derived from LepR + CD45 − -Ter119 − CD31 − CD51 + stromal cells in bone marrow 13 . Thus, we further assessed the effects of NMN on osteogenesis and adipogenesis of MSCs under irradiation in vitro and in vivo (Fig. 6a) . The frequency of AlizarinRed-S + osteoblastic cells increased by approximately threefold after NMN treatment (Fig. 6b) . Meanwhile, Oilred-O + adipocytes doubled after irradiation, whereas NMN treatment inhibited the growth of MAT (Fig. 6c) .
Interestingly, mRNA expression of the key osteogenic genes RunX2 and Wnt4 decreased by~50% with irradiation compared to the control, and NMN treatment lead to fivefold enhanced expression of these genes (Fig.  6d) . In addition, mRNA expression of adipogenic genes Adipq and Pparg increased with irradiation by approximately twofold but was inhibited in response to NMN treatment.
Next, we evaluated the effects of NMN on osteogenesis and adipogenesis of MSCs in vivo by µCT and Oil Red S staining in femur sections after irradiation (Fig. 6a) . µCT analysis showed that the cortical bone area and thickness did not change after irradiation or NMN treatment (Fig.  6f-j) . No percentile change was detected in trabecular bone volume in response to NMN treatment (Fig. 6l) . In , and cortical bone area/total area (f) (n = 6 mice per group, from six independent experiments). g Representative µCT images showing the trabecular bone. h-m µCT analyses of the trabecular bone volume/total volume (h), trabecular number (i), trabecular thickness (j), trabecular spacing (k), connectivity density (l), and structure model index (m) (n = 6 mice per group, from six independent experiments). n Quantification of the adipocyte number (n = 6 mice per group from six independent experiments). *p < 0.05, **p < 0.01 error bars, s.d.
contrast, we observed decreased trabecular number bỹ 50%, trabecular thickness by~30%, and trabecular bone connectivity density by~20% (Fig. 6m-p) , as well as increased trabecular spacing by~30% and structure model index by~50% after irradiation (Fig. 6o-q) . Importantly, NMN treatment reversed the changes in the above morphological parameters in trabecular bone after irradiation (Fig. 6m-q) . These results suggest that NMN promotes post irradiation osteoblast recovery in vivo, particular in the trabecular bone.
Furthermore, NMN treatment effectively inhibited the post irradiation adipogenesis by~66% (Fig. 6r, s) . Altogether, these results confirm our hypothesis that NMN supplementation encourages osteogenesis, but inhibits adipogenesis of MSCs after irradiation. We also noticed that osteoblast cells from irradiated mice have slightly increased (by 8%) proliferation and reduced (by 6%) apoptosis rate after NMN treatment in vitro (Fig. S3) . This suggested that NMN might have direct effect on osteoblast cells in irradiated mice. , and cortical bone area/total area (f) are shown (n = 6 mice per group, total, from six independent experiments). g Representative µCT images showing the trabecular bone. h-m µCT analyses of the trabecular bone volume/total volume (h), trabecular number (i), trabecular thickness (j), trabecular spacing (k), connectivity density (l), and structure model index (m) are (n = 6 mice per group from six independent experiments). n-o Representative Oil Red O and hematoxylin staining in femur sections (n) and quantification of the adipocyte number (o) (n = 6 mice per group from six independent experiments). *p < 0.05, **p < 0.01 error bars, s.d.
NMN controls bone-fat balance of MSCs differentiation through SIRT1
Next, we investigated the mechanism underlying NMN regulation of osteogenesis and adipogenesis in MSCs. SIRT1 promotes osteogenesis and inhibit adipogenesis 33 .
We found approximately twofold increase of SIRT1 protein in sorted LepR + CD45 − Ter119 − CD31 − CD51 + stromal cells from 12-month-old mice treatment with NMN ( Fig. 7a and S4A) . We further tested whether SIRT1 is required for the effects of NMN on MSCs in 15-monthold mice (Fig. S4B) . The CFU-F frequency and osteogenic capacity of MSCs in vitro were supressed, whereas the adipogenic capacity was derepressed by the SIRT1 inhibitor nicotinamide (Fig. 7b-d) . These results suggest that SIRT1 is crucial for NMN to promote osteogenesis and inhibit adipogenesis of MSCs.
To confirm our in vitro findings, we investigated osteogenesis and adipogenesis using the Prx1 cre; ColA1 flox-stopflox-SIRT1 mice (Fig. S4C) , which overexpresses SIRT1 protein in limb MSCs. We observed that cortical bone parameters in the femur diaphysis of Prx1 cre; ColA1 flox-stop-flox-SIRT1 mice were similar to their littermate controls (data not shown). Interestingly, although neither femur length nor the trabecular bone volume changed in Prx1 cre; ColA1 floxstop-flox-SIRT1 mice (Fig. 7f-h ), we detected doubled CFU-F frequency in enzymatically isolated BM (Fig. 7e) , which was NMN-treated and control mice (n = 3 independent experiments). e-f Representative µCT images showing vertical (e) and cross (f) sections of whole femur. g-j µCT analyses of the cortical bone thickness (g), cortical bone area (h), total area (i), and cortical bone area/total area (j) in the femur metaphysis (n = 6 mice per group from six independent experiments). k Representative µCT images showing trabecular bone from the femur metaphysis. l-q µCT analyses of the percentage of trabecular bone volume out of total volume (l), trabecular number (m), trabecular thickness (n), trabecular spacing (o), connectivity density (p), and structure model index (q) in the femur metaphysis (n = 6 mice per group from six independent experiments). r-s Representative Oil Red S and hematoxylin staining in femur sections (r) and quantification of the adipocyte number (s) (n = 6 mice per group from six independent experiments). *p < 0.05, **p < 0.01 error bars, s.d. potentially caused by overall strengthened trabecular bone in epiphysis region including substantially denser trabeculae structure, increased trabecular number by~60%, thickness by~25%, and trabecular bone connectivity density by~64% ( Fig. 7i-l) , as well as decreased trabecular spacing by~55% and structure model index by~40% (Fig. 7k-m) . Similar to NMN-treated mice, Prx1 cre; ColA1 flox-stop-flox-SIRT1 mice presented declined adipogenesis by~33% (Fig. 7n, o) . Altogether, these results confirm that the SIRT1 is required for NMN to control osteogenesis and adipogenesis in BM MSCs.
Discussion
Our results show that anti-aging agent NMN, can efficiently promote MSCs expansion in vivo and in vitro, not only in adult mice, but also in aged or irradiated mice. Mechanistically, SIRT1 protein upregulation plays an essential role in NMN's regulation of bone-fat balance. While skeletal aging and osteoporosis are characterized by dysregulation of MSC fate determination 34, 35 , our findings reveal a potential connection between NMN treatment and remedy in osteoporotic and aging mice.
Shortage of BM donation and extreme low ratio of MSCs in tissues necessitate in vitro expansion for clinical application of MSCs. However, most MSC expansion methods require frequent and prolonged subculturing, leading to proliferative exhaustion, senescence, compromised differentiation capacity of MSCs as well as heterogeneity resulted from spontaneous transformation 36 . Our study shows that NMN has the ability to promote MSCs expansion in vivo, which circumvented the issue of heterogeneity of in vitro culture and avoided prolonged subculturing.
Skeletal aging is featured by increased adipogenesis and reduced osteogenesis. Irradiated bone shares the similar characteristics with aged bones 31, 37 . Our study indicates that NMN enhance the bone-fat balance towards the bone lineage in aged and irradiated mice, suggesting that NMN is a valuable therapy for rescuing bone loss during aging.
Previous studies have shown that SIRT1 plays an important role in regulating osteogenesis and adipogenesis in human embryonic stem cells 33 . NMN rescues ageassociated susceptibility to acute kidney injury via a SIRT1-dependent pathway 38 . By using a SIRT1 inhibitor, we demonstrate that SIRT1 protein is essential for NMN to control the osteoblast and adipogenic lineage differentiation. Because of the high perinatal mortality of SIRT1 knockout mice and lack of SIRT1 loxp mice 39 , we were not able to study SIRT1 depletion in mice. We also noticed that Prx1 cre; ColA1 flox-stop-flox-SIRT1 mice with SIRT1 overexpression have more robust effect on bone formation than NMN treatment. This could be due to SIRT overexpression starting at embryonic stage in Prx1 cre; ColA1 flox-stop-flox-SIRT1 mice, whereas NMN treatment was not initiated until the adult stage.
In summary, we provide evidence for the novel role of NMN in regulating bone-fat imbalance through SIRT1 during skeletal aging. Our study establishes NMN as a promising potential therapy for MSCs expansion and rejuvenation of aged MSCs.
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